The present invention relates to HIV replication inhibitors of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein ring A and ring B represent phenyl, pyridyl, pyridazinyl, pyrimidinyl or pyrazinyl; n and m are 1 to 4; R1 represents hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; optionally substituted C1-6alkyl; C1-6alkyloxy C1-6alkylcarbonyl substituted with C1-6alkyloxycarbonyl; their use as a medicine, their use for the manufacture of a medicament for the treatment or the prevention of HIV infection; their processes for preparation and pharmaceutical compositions comprising them.
本发明涉及公式(I)的HIV复制
抑制剂,其中N-氧化物,药学上可接受的加盐物,季
铵盐或其立体
化学异构体形式,其中环A和环B代表苯基,
吡啶基,
吡啶并嗪基,
嘧啶基或
吡嗪基;n和m为1至4;R1代表氢;芳基;甲酰基;C1-6烷基羰基;C1-6烷氧羰基;可选择取代的C1-6烷基;C1-6烷氧基C1-6烷基羰基,其用作药物,用于制造用于治疗或预防HIV感染的药物的药物,其制备方法和包含它们的制药组合物。